Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 12:14 AM
NCT ID:
NCT01368458
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 18-64 with a SCID DSM-IV-TR diagnosis of schizophrenia or schizoaffective disorder, confirmed by SCID, who are able to give written informed consent and on stable dosages of two antipsychotics for at least one month prior to baseline.
Exclusion Criteria:
* Lack of capacity to give informed consent (capacity is determined by a licensed member of the treatment team)
* unstable medical illness
* use of long acting injectable preparations of antipsychotic medication in the previous two months
* documented failure of previous dose reduction
* current treatment with clozapine
* addition of any new psychotropic in the previous month
* patients who are severely assaultive and in clinical need of more than one antipsychotic for their safe management
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01368458
Study Brief:
Protocol Section:
NCT01368458